Next Science Limited is a medical technology company headquartered in Sydney, Australia, with a research and development centre in Florida, USA. It is listed on the ASX under ASX Code ‘NXS’. Next Science’s primary focus is the development and continued commercialisation of its proprietary XbioTM technology to reduce the impact of biofilm based infections in human health.

Email alerts

Enter your email address, then select the types of alert you’d like to subscribe to. Click ‘Submit’ to save your preferences.
If this is your first time subscribing, a confirmation email will be sent soon after you submit your preferences. Please open this email, and click the link listed inside to finalise your subscription to this service. You may return to this page at any time to modify your preferences.

Investor contacts

Investor queries

Next Science Limited
Level 19, Tower A, The Zenith
821 Pacific Highway, Chatswood
NSW 2067
Ph: +61 2 9375 7989
E: [email protected]

Share Registry queries

Link Market Services Limited
Level 12, 680 George Street
Sydney NSW 2000
Ph: 1300 554 474